Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies

Journal of Thoracic Disease, 08/05/2011

Senan S et al.– High–grade toxicity is uncommon when so–called ‘risk–adapted’ fractionation schemes are applied; an approach which involves the use of lower daily doses and more fractions when critical normal organs are in the proximity of the tumor volume.

Print Article Summary Cat 2 CME Report